RHYTHM PHARMACEUTICALS, INC. (RYTM) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $19.49M | +45.8% |
| 2024 | $13.37M | +43.7% |
| 2023 | $9.30M | +336.1% |
| 2022 | $2.13M | +256.1% |
| 2021 | $599.0K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $19.49M | +45.8% |
| 2024 | $13.37M | +43.7% |
| 2023 | $9.30M | +336.1% |
| 2022 | $2.13M | +256.1% |
| 2021 | $599.0K | — |